Cardlytics, Inc. Common StockCardlytics, Inc. Common StockCardlytics, Inc. Common Stock

Cardlytics, Inc. Common Stock

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪194.14 M‬USD
−6.11USD
‪−134.70 M‬USD
‪309.20 M‬USD
‪48.27 M‬
Beta (1Y)
1.78
Employees (FY)
434
Change (1Y)
−67 −13.37%
Revenue / Employee (1Y)
‪712.45 K‬USD
Net income / Employee (1Y)
‪−310.37 K‬USD

About Cardlytics, Inc. Common Stock


CEO
Amit Gupta
Headquarters
Atlanta
Founded
2008
FIGI
BBG00225ZDD0
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CDLX is 3.83 USD — it has decreased by −2.55% in the past 24 hours. Watch Cardlytics, Inc. Common Stock stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cardlytics, Inc. Common Stock stocks are traded under the ticker CDLX.
CDLX stock has fallen by −2.05% compared to the previous week, the month change is a −9.69% fall, over the last year Cardlytics, Inc. Common Stock has showed a −53.58% decrease.
We've gathered analysts' opinions on Cardlytics, Inc. Common Stock future price: according to them, CDLX price has a max estimate of 5.00 USD and a min estimate of 4.00 USD. Watch CDLX chart and read a more detailed Cardlytics, Inc. Common Stock stock forecast: see what analysts think of Cardlytics, Inc. Common Stock and suggest that you do with its stocks.
CDLX reached its all-time high on Feb 16, 2021 with the price of 161.47 USD, and its all-time low was 2.57 USD and was reached on Mar 24, 2023. View more price dynamics on CDLX chart.
See other stocks reaching their highest and lowest prices.
CDLX stock is 5.29% volatile and has beta coefficient of 1.78. Track Cardlytics, Inc. Common Stock stock price on the chart and check out the list of the most volatile stocks — is Cardlytics, Inc. Common Stock there?
Today Cardlytics, Inc. Common Stock has the market capitalization of ‪194.65 M‬, it has decreased by −6.14% over the last week.
Yes, you can track Cardlytics, Inc. Common Stock financials in yearly and quarterly reports right on TradingView.
Cardlytics, Inc. Common Stock is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
CDLX earnings for the last quarter are −2.90 USD per share, whereas the estimation was −0.57 USD resulting in a −411.76% surprise. The estimated earnings for the next quarter are −0.47 USD per share. See more details about Cardlytics, Inc. Common Stock earnings.
Cardlytics, Inc. Common Stock revenue for the last quarter amounts to ‪67.06 M‬ USD, despite the estimated figure of ‪57.77 M‬ USD. In the next quarter, revenue is expected to reach ‪64.29 M‬ USD.
CDLX net income for the last quarter is ‪−145.18 M‬ USD, while the quarter before that showed ‪−4.26 M‬ USD of net income which accounts for ‪−3.31 K‬% change. Track more Cardlytics, Inc. Common Stock financial stats to get the full picture.
No, CDLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 6, 2024, the company has 434.00 employees. See our rating of the largest employees — is Cardlytics, Inc. Common Stock on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cardlytics, Inc. Common Stock EBITDA is ‪−34.73 M‬ USD, and current EBITDA margin is −11.05%. See more stats in Cardlytics, Inc. Common Stock financial statements.
Like other stocks, CDLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cardlytics, Inc. Common Stock stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cardlytics, Inc. Common Stock technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cardlytics, Inc. Common Stock stock shows the sell signal. See more of Cardlytics, Inc. Common Stock technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.